Worst Pills, Best Pills Newsletter article, February 2010

Fesoterodine, which the Food and Drug Administration (FDA) approved in 2008, is the sixth drug on the market approved to treat overactive bladder.

In clinical trials, patients taking this drug urinated, on average, once less per day than those taking a placebo.